A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)

NCT06464588 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Dilated Cardiomyopathy

Interventions

BIOLOGICAL: Allogeneic Neonatal mesenchymal stromal cells (nMSCs)

Sponsor

Emory University

Collaborators

[object Object]